Study Type:	Interventional
Study Design:	Treatment, Randomized, Double Blind (Subject, Investigator), Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title:	A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multicenter Study of Weight-Reducing Effect and Safety in Obese Patients With Type 2 Diabetes

Ages Eligible for Study:	18 Years to 70 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Please refer to this study by its ClinicalTrials.gov identifier: NCT00029848

  Hide Study Locations

United States, Alabama

Innovative Clinical Trials

Birmingham, Alabama, United States, 35209

United States, Arizona

Advanced Clinicla Therapeutics, LLC

Tucson, Arizona, United States, 85712

Lovelace Scientific Resources

Phoenix, Arizona, United States, 85016

United States, California

Anderson Clinical Research

San Bernardino, California, United States, 92408

Diablo Clinical Research, Inc.

Walnut Creek, California, United States, 94598

Southern California Prevention and Research Center Inc. (SPARC)

Encino, California, United States, 91436

United States, Connecticut

North East Clinical Research

Hamden, Connecticut, United States, 06518

United States, Florida

Jacksonville Center for Clinical Research

Jacksonville, Florida, United States, 32216

Orlando Clinical Research Center

Orlando, Florida, United States, 32806

Clinical Research of South Florida

Coral Gables, Florida, United States, 33134

Metabolic Research Institute

West Palm Beach, Florida, United States, 33401

DMI Helathcare Group

Largo, Florida, United States, 33773

Comprehensive NeuroScience, Inc.

Sarasota, Florida, United States, 34232

Jackson Downey, MD

Jacksonville, Florida, United States, 32205

University Clinical Research

Pembroke Pines, Florida, United States, 33024

Jacksonville Center for Clinical Research

Jacksonville, Florida, United States, 32205

United States, Georgia

nTouch Research

Marietta, Georgia, United States, 30066

CSRA Partners in Health, Inc.

Augusta, Georgia, United States, 30909

United States, Indiana

Physicians Research Group

Indianapolis, Indiana, United States, 46250

MediSphere Medical Research Center, LLC

Evansville, Indiana, United States, 47714

United States, Kansas

Kansas University Medical Center

Kansas City, Kansas, United States, 66160

United States, Louisiana

Medical Research Institute

Slidell, Louisiana, United States, 70458

Gulf States Clinical Trails, LLC

Kenner, Louisiana, United States, 70062

United States, Maine

Androscoggin Cardiology Associates

Auburn, Maine, United States

United States, Massachusetts

Phase III Clinical Research

Fall River, Massachusetts, United States, 02720

JM Clinical Trials, Inc.

Swansea, Massachusetts, United States, 02777

United States, Minnesota

Twin Cities Clinical Research

Arden Hills, Minnesota, United States, 55126

United States, Nevada

Lovelace Scientific Resources

Las Vegas, Nevada, United States, 89014

United States, New Hampshire

Endocrinology and Diabetes Consultants, PC

Dover, New Hampshire, United States, 03820

United States, New Jersey

Radiant Reseach-Moorestown

Moorestown, New Jersey, United States, 08057

United States, New Mexico

Lovelace Scientific Resources

Albuquerque, New Mexico, United States, 87108

United States, New York

Physician Clinical Research Service

White Plains, New York, United States, 10605

United States, North Carolina

Center for Nutrition and Preventive Medicine

Charlotte, North Carolina, United States, 28207

United States, Ohio

Radiant Research

Cincinnati, Ohio, United States, 45236

MFP Research, Inc.

Cincinnati, Ohio, United States, 45242

United States, Oklahoma

University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, United States, 73104

United States, Oregon

Radiant Research

Portland, Oregon, United States, 97201

United States, South Carolina

Medical University of South Carolina, Division of Clinical Pharmacology

Charleston, South Carolina, United States, 29425

Costal Carolina Research Center

Mt. Pleasant, South Carolina, United States, 29464

United States, Tennessee

TriCities Medical Reseach

Bristol, Tennessee, United States, 37620

United States, Texas

Diabetes $ Glandular Disease Clinic, PA

San Antonio, Texas, United States, 78229-4810

United States, Utah

Endocrine and Diabetes

Ogden, Utah, United States, 84403

United States, Virginia

National Clinical Research

Richmond, Virginia, United States, 23294

Salem Veterans Affairs Medical Center (151)

Salem, Virginia, United States, 24153

The Chase Wellness Center, Inc.

Virginia Beach, Virginia, United States, 23455

Argentina

Sanofi-aventis Administrative Office

Buenos Aires, Argentina

Belgium

Sanofi-aventis Administrative Office

Diegem, Belgium

Canada

Sanofi-aventis Administrative Office

Laval, Canada

Czech Republic

Sanofi-aventis Administrative Office

Praha, Czech Republic

Finland

Sanofi-aventis Administrative Office

Helsinki, Finland

France

Sanofi-aventis Administrative Office

Paris, France

Germany

Sanofi-aventis Administrative Office

Berlin, Germany

Netherlands

Sanofi-aventis Administrative Office

Gouda, Netherlands

Poland

Sanofi-aventis Administrative office

Warszawa, Poland

United Kingdom

Sanofi-aventis Administrative Office

Guildford Surrey, United Kingdom

Study Director:

ICD CSD

Sanofi-Aventis

Additional Information:
Publications:

Responsible Party:	sanofi-aventis ( ICD Study Director )
Study ID Numbers:	EFC4736
Study First Received:	January 23, 2002
Last Updated:	April 17, 2009
ClinicalTrials.gov Identifier:	NCT00029848     History of Changes
Health Authority:	United States: Food and Drug Administration

Keywords provided by Sanofi-Aventis:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on November 25, 2009